Predict your next investment

BD company logo
Corporation
HEALTHCARE | Medical Equipment & Supplies
bd.com

See what CB Insights has to offer

Investments

10

Portfolio Exits

9

Partners & Customers

10

Service Providers

1

About BD

BD is a medical technology company that manufactures and sells a broad range of supplies, devices, and systems for use by healthcare professionals, medical research institutions, industry, and the general public.

BD Headquarter Location

1 Becton Drive

Franklin Lakes, New Jersey, 07417,

United States

201-847-6800

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing BD

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find BD in 4 Expert Collections, including Fortune 500 Investor list.

F

Fortune 500 Investor list

590 items

This is a collection of investors named in the 2019 Fortune 500 list of companies. All CB Insights profiles for active investment arms of a Fortune 500 company are included.

C

Conference Exhibitors

5,302 items

M

Medical Devices

4,399 items

https://www.advamed.org/membership-join/membership-directory/ - excludes those without working websites.

H

Health Monitoring & Diagnostics

701 items

Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting

BD Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

BD Rank

Latest BD News

Global Disposable Syringes Sourcing and Procurement Market to Grow by USD 2.63 Billion | Dominant Vendors Includes B. Braun Melsungen, Becton Dickinson and Company, and Codan Medizinische Gerate Among Others | SpendEdge

Jun 24, 2022

| Dominant Vendors Includes B. Braun Melsungen, Becton Dickinson and Company, and Codan Medizinische Gerate Among Others | SpendEdge News provided by Share this article More than 100 CPOs and 500 category managers use our insights daily SpendEdge has the fastest growth rate in number of reports and client base NEW YORK, June 24, 2022 /PRNewswire/ -- The Disposable Syringes market size is expected to grow by USD 2.63 Billion by 2026, at a Compound Annual Growth Rate (CAGR) of 6.05% during the forecast period. To know more about this market. Disposable Syringes Market Analysis Analysis of the cost and volume drivers and supply market forecasts in various regions are offered in this Disposable Syringes research report. This market intelligence report also analyzes the top supply markets, market opportunities, challenges and the critical cost drivers that can aid buyers and suppliers devise a cost-effective category management strategy. To get instant access to over 1000 market-ready procurement intelligence reports without any additional costs or commitment. Regional spend dynamism and factors impacting costs The total cost of ownership and cost-saving opportunities Supply chain margins and pricing models Competitiveness index for suppliers Supplier and buyer KPIs around the "Disposable Syringes Market." Report Metrics Leading Disposable Syringes suppliers Top Pricing Models Best Selling Procurement Research Report: Wireline Logging Services - Forecast and Analysis : The Disposable Syringes will grow at a CAGR of 5.50% during 2021-2025. Prices will increase by 3%-5% during the forecast period and suppliers will have moderate bargaining power in this market. Data Feed Management- Sourcing and Procurement Intelligence Report : The report provides a complete drill-down on global data feed management services spend outlook at a global as well as regional level. Current spend scenario, growth outlook, incremental spend, and other key information is available individually for North America, South America, Europe, Middle East and Africa, and APAC. This procurement report answers help buyers identify and shortlist the most suitable suppliers for their Disposable Syringes Market requirements following questions: Am I engaging with the right suppliers? Which KPIs should I use to evaluate my incumbent suppliers? Which supplier selection criteria are relevant for? What are the workplace computing devices category essentials in terms of SLAs and RFx? Table of Content

BD Investments

10 Investments

BD has made 10 investments. Their latest investment was in Islacare as part of their Corporate Minority on May 5, 2022.

CBI Logo

BD Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/13/2022

Corporate Minority

Islacare

Yes

1

8/16/2017

Series A

MedAware

$8M

Yes

3

2/23/2016

Series D

DiabetOmics

$4.8M

Yes

1

4/6/2015

Grant - II

Subscribe to see more

$99M

Subscribe to see more

10

11/16/2010

Series A

Subscribe to see more

$99M

Subscribe to see more

0

Date

5/13/2022

8/16/2017

2/23/2016

4/6/2015

11/16/2010

Round

Corporate Minority

Series A

Series D

Grant - II

Series A

Company

Islacare

MedAware

DiabetOmics

Subscribe to see more

Subscribe to see more

Amount

$8M

$4.8M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

3

1

10

0

BD Portfolio Exits

9 Portfolio Exits

BD has 9 portfolio exits. Their latest portfolio exit was embecta on April 01, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/1/2022

Spinoff / Spinout

embecta

$99M

2

10/25/2018

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

9/7/2018

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

2/15/2018

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

3/9/2016

Divestiture

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/1/2022

10/25/2018

9/7/2018

2/15/2018

3/9/2016

Exit

Spinoff / Spinout

Divestiture

Divestiture

Divestiture

Divestiture

Companies

embecta

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

10

BD Acquisitions

27 Acquisitions

BD acquired 27 companies. Their latest acquisition was Parata on June 06, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

6/6/2022

$99M

Acquired - II

3

2/1/2022

Growth Equity

$99M

$3.02M

Acquired

8

12/21/2021

Other

$99M

$5.47M

Acquired

8

12/9/2021

Other

Subscribe to see more

$99M

$99M

Subscribe to see more

10

12/2/2021

Debt

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

6/6/2022

2/1/2022

12/21/2021

12/9/2021

12/2/2021

Investment Stage

Growth Equity

Other

Other

Debt

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$3.02M

$5.47M

$99M

$99M

Note

Acquired - II

Acquired

Acquired

Subscribe to see more

Subscribe to see more

Sources

3

8

8

10

10

BD Partners & Customers

10 Partners and customers

BD has 10 strategic partners and customers. BD recently partnered with Mayo Clinic on June 6, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

6/14/2022

Partner

United States

1

6/9/2022

Partner

Spain

1

5/11/2022

Partner

United States

06:50 EDT Babson, BD Expand Strategic Partnership to Advance Diagnostic Blood Collection in New Care Settings

`` Today 's agreement expands our long-standing partnership with BD and builds on our shared passion of making convenient blood testing accessible to all , not only in the U.S. , but also globally , '' said David Stein , chief executive officer of Babson Diagnostics .

3

5/4/2022

Sponsored

United Kingdom

Subscribe to see more

Subscribe to see more

10

2/8/2022

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

6/14/2022

6/9/2022

5/11/2022

5/4/2022

2/8/2022

Type

Partner

Partner

Partner

Sponsored

Partner

Business Partner

Country

United States

Spain

United States

United Kingdom

United States

News Snippet

06:50 EDT Babson, BD Expand Strategic Partnership to Advance Diagnostic Blood Collection in New Care Settings

`` Today 's agreement expands our long-standing partnership with BD and builds on our shared passion of making convenient blood testing accessible to all , not only in the U.S. , but also globally , '' said David Stein , chief executive officer of Babson Diagnostics .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

1

3

10

10

BD Service Providers

1 Service Provider

BD has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Acq - P2P, and Acquired - II

Investment Bank

Financial Advisor

Service Provider

Associated Rounds

Acq - P2P, and Acquired - II

Provider Type

Investment Bank

Service Type

Financial Advisor

Partnership data by VentureSource

BD Team

34 Team Members

BD has 34 team members, including current Chief Executive Officer, President, Devdatt (Dev) Kurdikar.

Name

Work History

Title

Status

Tom Isett

Founder

Current

Devdatt (Dev) Kurdikar

Chief Executive Officer, President

Current

Tom Polen

Chief Executive Officer, President

Current

Kevin Egesborg

President, Managing Director

Current

Tony Ezell

President, Chief Marketing Officer, Executive Vice President

Current

Name

Tom Isett

Devdatt (Dev) Kurdikar

Tom Polen

Kevin Egesborg

Tony Ezell

Work History

Title

Founder

Chief Executive Officer, President

Chief Executive Officer, President

President, Managing Director

President, Chief Marketing Officer, Executive Vice President

Status

Current

Current

Current

Current

Current

You May Also Like

I
Iaculor Injection

Iaculor Injection Inc. develops low cost, more efficient needle-free injection devices that allow the delivery of powder or liquid forms of vaccines, small molecules and biologicals.

OncoHost Logo
OncoHost

OncoHost combines life-science research and advanced machine learning technology to develop personalized strategies to maximize the success of cancer therapy. Utilizing proprietary proteomic analysis, the company aims to understand patients' unique response to therapy and overcome one of the major obstacles in clinical oncology: resistance to therapy. OncoHost's host response profiling platform, PROphet®, analyzes proteomic changes in blood samples to monitor the dynamics of biological processes induced by the patient (i.e. the host) in response to a given cancer therapy. This proteomic profile is highly predictive of individual patient outcome, thus enabling personalized treatment planning. PROphet® also identifies potential drug targets, advancing the development of therapeutic strategies, as well as rationally-based combination therapies. The company was founded in 2017 and is based in Binyamina, Israel.

Ovizio Logo
Ovizio

Ovizio develops efficient quantitative microscopy solutions for life sciences applications. The company's microscopes offer easy-to-use, label-free and non-invasive tools for real-time 3D imaging of living cells. Validated with almost every type of transparent cell culture vessel, Ovizio's devices can track cell count, cell morphology and cell viability with the highest reproducibility at a single cell level. Applicable from R&D to manufacturing processes and enabling significant cost reductions and quality improvement, Ovizio's microscopes are particularly convenient and robust for automated cell culture monitoring, analysis and quality control.

Quest Diagnostics Logo
Quest Diagnostics

Quest Diagnostics offers medical diagnostic testing and services throughout the United States. The company has international presence, including laboratory operations in the United Kingdom, Mexico, Puerto Rico, and India.

S
StethoMe

StethoMe focuses on the development of artificial intelligence in the fields of healthcare and telemedicine. Its core product is an electronic stethoscope that coordinates with a smartphone app and specially designed algorithms - StethoMe AI.

PixCell Medical Technologies Logo
PixCell Medical Technologies

PixCell Medical Technologies is a privately held company developing cell-based diagnostics for the point of care (POC), based on its viscoelastic focusing and microfluidics technology. The company's core technology is comprised of an analyzer and a self-contained disposable cartridge.On May 3, 2021, PixCell Medical Technologies was acquired by Soulbrain. The terms of the transaction were not disclosed.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.